-
A two-year prospective cohort study of children less than five years of age presenting with a febrile illness (¡Ý 38.0¡ã C) to a single emergency department in Australia, used a standardized clinical evaluation with a mandatory entry for 40 clinical features between July 1, 2004, and June 30, 2006.
-
In this study, 8,402 patients from seven case-control series were examined in this trial. The series included Kenyan children with bacteremia, patients with tuberculosis (TB) in Malawi, Hong Kong, and Gambia, and patients with severe malaria in Gambia, Kenya, and Vietnam. Standard methods for genotyping selected genes in PBMCs were employed.
-
-
Piperacillin/Tazobactam (P/T) offers one of the broadest antimicrobial spectrums, and is equipped with an effective mechanism to maintain its potency in the presence of beta-lactamases.
-
These authors assessed the benefits of antiviral therapy of the index flu patient on reduced viral shedding and prevention of secondary household cases who did not receive chemoprophylaxis.
-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
Twenty-one patients with HIV-1/AIDS, seven patients with hiv-2/aids, 43 patients with HIV-1 chronic infection, and 66 patients with HIV-2 chronic infection in Guinea-Bissau were studied along with 66 HIV-negative policemen.
-
CD4+ t cells were obtained from HIV-negative donors and HIV-positive patients receiving HAART with suppressed viremia. Using a single-cycle replication system and an X4 pseudovirus used to infect cells, minocycline, at concentrations from 0-50 ug/mL, demonstrated a dose-dependent reduction in the percentage of infected cells.
-
-
An open-label, randomized, controlled trial of early vs. delayed initiation of HAART was conducted in 642 patients with active TB and HIV infection in Durban, South Africa.
